Barcelona, Spain

Angel Messeguer Peypoch


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Angel Messeguer Peypoch

Introduction

Angel Messeguer Peypoch is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of neuroprotection through his innovative research and patents. His work focuses on developing compounds that can protect neurons from excitotoxic damage, which is crucial for treating various neurodegenerative disorders.

Latest Patents

Angel Messeguer Peypoch holds a patent for "N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres." This patent describes a range of N-alkylglycine trimeres, their stereoisomers, racemic mixtures, and salts that are effective in blocking L-glutamate receptors. These compounds are particularly useful in treating disorders such as cerebral ischemia, migraine, depression, Huntington's disease, Parkinson's disease, Alzheimer's disease, senile dementia, epilepsy, and amyotrophic lateral sclerosis. He has 1 patent to his name.

Career Highlights

Angel Messeguer Peypoch is associated with Diverdrugs, S.L., a company dedicated to developing innovative pharmaceutical solutions. His research has paved the way for new therapeutic approaches in neuroprotection, showcasing his commitment to advancing medical science.

Collaborations

He has collaborated with notable colleagues, including Vicente Felipo Orts and Carmen Montoliu Felix, to further enhance the impact of his research and innovations.

Conclusion

Angel Messeguer Peypoch's contributions to neuroprotection through his patented inventions highlight his role as a significant figure in the field of medical research. His work continues to inspire advancements in treatments for neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…